Gene: CD99L2
Official Full Name: CD99 molecule like 2provided by HGNC
Gene Summary: This gene encodes a cell-surface protein that is similar to CD99. A similar protein in mouse functions as an adhesion molecule during leukocyte extravasation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25411 | CD99L2 Knockout cell line (HeLa) | Human | CD99L2 | 1:3~1:6 | Negative | Online Inquiry |
KO25412 | CD99L2 Knockout cell line (HCT 116) | Human | CD99L2 | 1:2~1:4 | Negative | Online Inquiry |
KO25413 | CD99L2 Knockout cell line (HEK293) | Human | CD99L2 | 1:3~1:6 | Negative | Online Inquiry |
KO25414 | CD99L2 Knockout cell line (A549) | Human | CD99L2 | 1:3~1:4 | Negative | Online Inquiry |
CD99L2 Gene Knockout Cell Lines are genetically modified cell lines designed to feature a targeted deletion of the CD99L2 gene, which plays a significant role in cellular processes including immune responses and cell adhesion. By employing advanced CRISPR-Cas9 technology, these cell lines provide researchers with precise tools to dissect the functions of CD99L2, elucidate its role in various biological pathways, and investigate its implications in diseases such as cancer and immune disorders.
The primary mechanism of action occurs through the disruption of the CD99L2 gene, which leads to altered expression levels of downstream signaling pathways critical for various cellular functions. By effectively knocking out this gene, scientists can study phenotypic changes, including modifications in cell proliferation, migration, and interaction with other immune components. This functional insight is paramount for understanding how abnormalities in CD99L2 may contribute to pathophysiological conditions.
In scientific research and clinical applications, CD99L2 Gene Knockout Cell Lines are invaluable for investigating immune modulation, cancer biology, and therapeutic resistance. Their utility extends to drug discovery, biomarker validation, and the development of personalized treatment strategies, presenting essential data that can facilitate the development of novel therapeutics.
What sets our CD99L2 Gene Knockout Cell Lines apart from existing alternatives is the rigor of our validation process, confirming functional competency and reproducibility across multiple experimental conditions. These highly characterized cell lines save researchers time and resources while providing robust, reliable results.
For researchers, clinicians, and pharmaceutical companies, the value of easily accessible, high-quality CD99L2 Gene Knockout Cell Lines cannot be overstated. They offer an innovative platform for groundbreaking research, enhancing our understanding of complex biological systems and paving the way for transformative medical advancements.
Our company prides itself on its extensive expertise in developing and providing cutting-edge biological products. With a focus on innovation and quality, we are committed to empowering researchers and clinicians alike in their quest to unravel the intricacies of health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.